Stock Research Monitor: IPAS, KT, and TEF

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on VEON sign up now at www.wallstequities.com/registration. This morning, WallStEquities.com presents four Foreign Telecom Services companies to see how they have fared over the past trading sessions: iPass Inc. (NASDAQ: IPAS), KT Corp. (NYSE: KT), Telefonica S.A. (NYSE: TEF), and VEON Ltd (NASDAQ: VEON). The Telecommunications Services sector comprises companies that provide communications services primarily through a fixed-line, cellular, wireless, high-bandwidth, and/or fiber optic cable network. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

iPass

Redwood Shores, California headquartered iPass Inc.’s stock finished Wednesday’s session 3.20% lower at $0.39 with a total trading volume of 303,786 shares. The Company’s shares have advanced 24.90% in the past month. The stock is trading 9.26% above its 50-day moving average. Additionally, shares of iPass, which provides mobile connectivity that enables Wi-Fi access on various mobile devices in the US and internationally, have a Relative Strength Index (RSI) of 54.70.

On May 29th, 2018, iPass announced that it will be presenting at the 1st Annual Ladenburg Thalmann Tech Expo Conference on May 31st, 2018 at 2:30 p.m. EDT at Convene in New York City. Gary Griffiths, president and CEO, will be presenting and will also be meeting with investors. Get the full research report on IPAS for free by clicking below at:

www.wallstequities.com/registration/?symbol=IPAS

KT Corp.

On Wednesday, shares in Seongnam, South Korea headquartered KT Corp. recorded a trading volume of 377,732 shares. The stock ended the session 0.61% higher at $13.15. The Company’s shares are trading 1.98% below their 50-day moving average. Moreover, shares of KT Corp., which provides telecommunications services in Korea, have an RSI of 45.74.

On May 09th, 2018, KT Corp. announced that it has filed its Annual Report on Form 20-F for the year ended December 31st, 2017, with the US SEC. The report can be accessed on the Company’s English website as well as the SEC’s EDGAR database. Download our actionable research report on KT at:

www.wallstequities.com/registration/?symbol=KT

Telefonica

Madrid, Spain-based Telefonica S.A.’s shares closed the day 1.49% higher at $8.86. The stock recorded a trading volume of 1.44 million shares, which was higher than its three months average volume of 1.18 million shares. The Company’s shares are trading 9.55% below their 50-day moving average. Additionally, shares of Telefonica, which provides mobile and fixed communication services primarily in the European Union and Latin America, have an RSI of 22.88. Register for your free report coverage on TEF at:

www.wallstequities.com/registration/?symbol=TEF

VEON Ltd

Shares in Amsterdam, the Netherlands headquartered VEON Ltd finished 1.69% higher at $2.40. The stock recorded a trading volume of 3.03 million shares. The Company’s shares are trading below their 50-day moving average by 7.44%. Furthermore, shares of VEON, which through its subsidiaries, provides mobile and fixed-line telecommunications services, have an RSI of 34.10.

On May 14th, 2018, VEON announced its results for the quarter ended March 31st, 2018. Total revenue for Q1 2018 was USD 2,250 million, reported EBITDA was USD 854 million, and EBITDA margin was 38.0%. Equity free cash flow excluding licenses totaled USD 334 million in the quarter, and net debt to LTM EBITDA was 2.5x. Get the free research report on VEON at:

www.wallstequities.com/registration/?symbol=VEON

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 501365

Stock Research Monitor: HGV, ILG, and LVS

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on LQ sign up now at www.wallstequities.com/registration. On Wednesday, May 30, 2018, the NASDAQ Composite ended the trading session at 7,462.45, up 0.89%; the Dow Jones Industrial Average edged 1.26% higher, to finish at 24,667.78; and the S&P 500 closed at 2,724.01, advancing 1.27%. Gains were broad based as all sectors ended the day in positive. This Thursday, WallStEquities.com has initiated reports coverage on the following Resorts & Casinos equities: Hilton Grand Vacations Inc. (NYSE: HGV), ILG Inc. (NASDAQ: ILG), La Quinta Holdings Inc. (NYSE: LQ), and Las Vegas Sands Corp. (NYSE: LVS). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Hilton Grand Vacations

Orlando, Florida headquartered Hilton Grand Vacations Inc.’s stock finished Wednesday’s session 2.39% higher at $40.32 with a total trading volume of 980,585 shares. The Company’s shares have advanced 12.69% over the past twelve months. The stock is trading below its 50-day moving average by 4.09%. Additionally, shares of the Company, which develops, markets, sells, and manages timeshare resorts primarily under the Hilton Grand Vacations brand, have a Relative Strength Index (RSI) of 47.61. Get the full research report on HGV for free by clicking below at:

www.wallstequities.com/registration/?symbol=HGV

ILG Inc.

On Wednesday, shares in Miami, Florida headquartered ILG Inc. recorded a trading volume of 3.38 million shares, which is above its three months average volume of 2.06 million shares. The stock ended the session 2.06% higher at $34.60. The Company’s shares have advanced 13.97% in the previous three months and 29.73% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 5.39% and 15.48%, respectively. Moreover, shares of ILG, which together with its subsidiaries, provides professional vacation services in the US and internationally, have an RSI of 66.97. Get access to our top-rated research, including the free report on ILG at:

www.wallstequities.com/registration/?symbol=ILG

La Quinta Holdings

Irving, Texas headquartered La Quinta Holdings Inc.’s shares closed the day 5.10% higher at $21.62. The stock recorded a trading volume of 3.78 million shares, which is above its three months average volume of 1.61 million shares. The Company’s shares have gained 10.64% in the last month, 14.51% over the previous three months, and 54.54% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 10.47% and 18.62%, respectively. Additionally, shares of La Quinta, which owns, operates, and franchises select-service hotels, have an RSI of 78.00. Click here to subscribe for a free membership which welcomes you with our report on LQ at:

www.wallstequities.com/registration/?symbol=LQ

Las Vegas Sands

Shares in Nevada-based Las Vegas Sands Corp. finished 0.85% higher at $80.26. The stock recorded a trading volume of 2.25 million shares. The Company’s shares have advanced 10.23% in the previous three months and 36.73% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 7.85% and 15.26%, respectively. Furthermore, shares of the Company, which together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the US, have an RSI of 71.68. Join our big investor community at Wall St. Equities today and get your free report on LVS at:

www.wallstequities.com/registration/?symbol=LVS

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 501366

Stock Research Monitor: AVDL, CDMO, and BPMC

LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on CASI sign up now at www.wallstequities.com/registration. On Wednesday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the trading session up 0.89%; the Dow Jones Industrial Average edged 1.26% higher; and the S&P 500 was up 1.27%. US markets made broad based gains with all sectors finishing the day in green. Pre-market today, WallStEquities.com reviews these four Biotechnology stocks: Avadel Pharmaceuticals PLC (NASDAQ: AVDL), Avid Bioservices Inc. (NASDAQ: CDMO), Blueprint Medicines Corp. (NASDAQ: BPMC), and CASI Pharmaceuticals Inc. (NASDAQ: CASI). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Avadel Pharmaceuticals

Dublin, Ireland headquartered Avadel Pharmaceuticals PLC’s stock finished Wednesday’s session 3.56% higher at $6.69. A total volume of 273,392 shares was traded. The Company’s shares have advanced 0.90% in the past month. The stock is trading below its 50-day moving average by 4.58%. Furthermore, shares of Avadel Pharma, which develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines in the US, France, and Ireland, have a Relative Strength Index (RSI) of 47.02. Get the full research report on AVDL for free by clicking below at:

www.wallstequities.com/registration/?symbol=AVDL

Avid Bioservices

Shares in Tustin, California-based Avid Bioservices Inc. ended at $3.23, down 4.44% from the last trading session. The stock recorded a trading volume of 194,589 shares. The Company’s shares have gained 31.30% over the previous three months. The stock is trading below its 50-day moving average by 1.88%. Moreover, shares of Avid Bioservices, which operates as a contract development and manufacturing organization focusing on the development and cGMP manufacture of biopharmaceutical products derived from mammalian cell culture, have an RSI of 38.36. CDMO’s complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=CDMO

Blueprint Medicines

Cambridge, Massachusetts headquartered Blueprint Medicines Corp.’s stock ended yesterday’s session 1.21% higher at $82.50 with a total trading volume of 227,324 shares. The Company’s shares have advanced 133.38% in the last twelve months. The stock is trading above its 200-day moving average by 9.58%. Additionally, shares of Blueprint Medicines, which develops drugs of small molecule kinase inhibitors that target genomic drivers in various cancers and a rare genetic disease, have an RSI of 50.04. Are you already registered with Wall St. Equities? Do so now for free, and get the report on BPMC at:

www.wallstequities.com/registration/?symbol=BPMC

CASI Pharmaceuticals

On Wednesday, shares in Rockville, Maryland headquartered CASI Pharmaceuticals Inc. recorded a trading volume of 232,487 shares. The stock finished the day 2.50% higher at $6.55. The Company’s shares have advanced 89.31% in the previous three months and 568.37% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 1.96% and 79.62%, respectively. Furthermore, shares of CASI Pharma, which focuses on the acquisition, development, and commercialization of therapeutics addressing cancer and other unmet medical needs in China, have an RSI of 46.20. Aspiring Member, please take a moment to register below for your free research report on CASI at:

www.wallstequities.com/registration/?symbol=CASI

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 501367

LOS ANGELES, CA / ACCESSWIRE / May 31, 2018 / IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced that it will be presenting at the 8th annual LD Micro Invitational on Tuesday, June 5th at 9:30 AM PST /12:30 PM EST. Tom LaVoy, CEO of IsoRay, will be giving the presentation and meeting with investors throughout the conference.

“The event is slated to be our largest Invitational to date,” stated Chris Lahiji, President of LD Micro. “When the fires caused the cancellation of our Main Event back in December, we vowed to come back even stronger. This event showcases our firm’s ability to attract the most unique and exciting names in micro-cap.”

The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap/micro-cap space, and will be attended by over 1,000 individuals.

View IsoRay’s profile here: https://www.ldmicro.com/profile/ISR.

Profiles powered by LD Micro – News Compliments of Accesswire.

About IsoRay, Inc.

IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Join us on Facebook/IsoRay. Follow us on Twitter @IsoRay.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contacts:

IsoRay, Inc.
info@isoray.com
(509) 375-1202

Investors:

Stephanie Prince, Managing Director
PCG Advisory Group
sprince@pcgadvisory.com
(646) 762-4518

SOURCE: IsoRay

ReleaseID: 501078

VANCOUVER, BC / ACCESSWIRE / May 31, 2018 / MGX Minerals Inc. (”MGX” or the ”Company”) (CSE: XMG; FKT: 1MG; OTCQB: MGXMF) and engineering partner PurLucid Treatment Solutions Inc. (”PurLucid”) are pleased to report that, prior to deployment, demonstration of the NFLi-5 commercial-scale rapid lithium extraction system, capable of processing 750 barrels per day (120 cubic meters), is scheduled to take place immediately with oil and gas companies, industrial customers, lithium brine owners and international media scheduled to view the system. Demonstration of the lithium and petrolithium extraction and water treatment system will take place in the first half of June at the PurLucid manufacturing facility in Calgary, Alberta.

In addition to the NFLi-5 system, MGX and PurLucid have fabricated three customized wastewater treatment systems unique to each client / partner’s needs and all capable of lithium, minerals, slop oil and heavy metals separation. The first system, which is scheduled for deployment to an oil and gas operation in Alberta, is an evaporator blowdown wastewater treatment system (10 m3/hr) which will take highly concentrated evaporator brine and treat it to a level suitable for reinjection on site. The second system, which represents a contract between a consortium of partners, is a high temperature system that will be installed to treat produced water following oil-water separation. The third system is a larger-scale version (35 m3/h) of the first system intended for deployment to treat one-through steam generator (”OTSG”) boiler blowdown.

Petrolithium Technology

PurLucid water treatment technologies, which purify wastewater brine, have been integrated with a newly developed lithium recovery process. Combined, this Cleantech process reduces the capital cost of recovery compared to traditional solar evaporation as it does not require the investment in large, multi-phase, lake sized, lined evaporation ponds, greatly reducing the physical footprint and enhancing the quality of extraction and recovery across a complex range of brines previously considered un-processable due to complexity or geographical location outside of solar evaporation appropriate zones. This includes oil and gas wastewater, natural brine, and other brine sources such as lithium-rich mine and industrial plant wastewater. MGX holds the global rights to the jointly developed lithium extraction technology while PurLucid retains the rights to the pre-treatment water purification and core technology.

The technology was recently chosen as winner of the Base and Specialty Metals Industry Leadership Award at the 2018 S&P Global Platts Global Metals Awards, held in London earlier this month (see press release dated May 18, 2018). Hosted by S&P Global Platts, a leading global energy, metals and commodities information provider, the annual awards program honored exemplary performance in fifteen categories spanning the entire steel, metals and mining complex.

About PurLucid

PurLucid’s exclusively licensed and patented nanoflotation technology was designed specifically for oilfield environments. The technology separates impurities from oil and gas wastewater and produces clean water as a final product. This allows for the recycling or controlled release of oilfield wastewater and reduces or eliminates downhole and associated transportation costs. Water handling costs are one of the largest operating costs in the oilfield and oilsands operations today. Learn more at www.purlucid.com. MGX currently holds a 51% interest in PurLucid and maintains the right to acquire 100% through successive future investments.

About MGX Minerals

MGX Minerals is a diversified Canadian resource company with interests in advanced material and energy assets throughout North America. Learn more at www.mgxminerals.com.

Contact Information

Jared Lazerson
President and CEO
Telephone: 1.604.681.7735
Web: www.mgxminerals.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements (collectively “forward-looking information”) within the meaning of applicable securities laws. Forward-looking information is typically identified by words such as: “believe”, “expect”, “anticipate”, “intend”, “estimate”, “potentially” and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance, and that actual results may differ materially from those in forward-looking information as a result of various factors. The reader is referred to the Company’s public filings for a more complete discussion of such risk factors and their potential effects which may be accessed through the Company’s profile on SEDAR at www.sedar.com.

SOURCE: MGX Minerals Inc.

ReleaseID: 501301

LOS ANGELES, CA / ACCESSWIRE / May 31, 2018 / StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Jim Reynolds, President & CEO of ADOMANI, Inc. (NASDAQ: ADOM), a provider of zero-emission electric and hybrid vehicles and replacement drivetrains that is focused on reducing the total cost of vehicle ownership, according to the company’s website (see here: www.adomanielectric.com). The video interview was recorded on Wednesday, April 25, 2018 at the Planet MicroCap Showcase 2018 in Las Vegas, NV.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

ADOMANI, Inc. – Provider of Zero-Emission Electric and Hybrid Vehicles and Replacement Drivetrains with Primary Focus on School Buses

You can follow Stock News Now on FACEBOOK, TWITTER, LINKEDIN, YOUTUBE, and STOCKTWITS

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer.

About ADOMANI®

ADOMANI, Inc. is a provider of zero-emission electric and hybrid vehicles and replacement drivetrains that is focused on reducing the total cost of vehicle ownership. ADOMANI® drivetrain systems are designed to help fleet operators unlock the benefits of green technology and address the challenges of traditional fuel price cost instability and local, state and federal environmental regulatory compliance. ADOMANI® designs and causes to be designed advanced zero-emission electric and hybrid drivetrain systems for integration in new school buses and medium to heavy-duty commercial fleet vehicles. For more information visit www.ADOMANIelectric.com.

About StockNewsNow.com

StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.

Follow the companies YOU want to know more about; read and watch content from YOUR favorite microcap, emerging growth financial experts; register to attend financial conferences of YOUR choosing; find microcap and emerging growth financial professionals that YOU may be looking for – all here on StockNewsNow.com.

info@stocknewsnow.com

SOURCE: StockNewsNow.com

ReleaseID: 501325

Great Expectations for Railroad Valley to Help Meet the Increasing Demand for Lithium

INCLINE VILLAGE, NV / ACCESSWIRE / May 31, 2018 / LithiumOre (http://lithiumore.net) (the “Company”), a wholly-owned subsidiary of Oroplata Resources, Inc. (OTCQB: ORRP), a lithium resource exploration and development company, is pleased to share its visionary business strategy.

In a recent press release, Mr. Vincent Ramirez, Chief Executive Officer of 3PL Operating, LithiumOre’s partner, detailed the lithium dynamics of Railroad Valley Nevada. It demonstrated that Railroad Valley has potentially immense lithium resources that could make it the largest lithium brine deposit in the world. We are in the process of testing these brine deposits on our claims. Our land is positioned in the deepest part of the former lake bed. If this proves out, then all the acreage we have and the surrounding area are considered to have the same deposits. If that is the case, then all our claims can be considered to have the same quality lithium resources as the initial drillings. This would make us very similar to shale oil producers that initially used fracking to develop their oil fields. Upon proving out the model the amount of lithium in the Company’s claims will be quantifiable and provable. We believe we can utilize acreage the same way that the shale oil producers use acreage to determine how much net recoverable oil is underneath their land. Based upon information from our partner 3PL, we believe this could be over one million tons of lithium hydroxide. Recently lithium hydroxide has been selling for over $20,000 a ton.

Petroleum-based fuels like gasoline and diesel have dominated the transportation sector for the last century – and they still do. However, policymakers and technocrats are looking toward electric vehicles (EV) to move away from gasoline and diesel. With the support of favorable policies and consumer preferences, EVs, led by Tesla’s lineup, are taking off. Already, more than a half million EVs are on the roads in the U.S. and more than a million are on roads worldwide. Dropping internal combustion engines in favor of EVs would seemingly be at odds with the idea of increasing domestic oil and gas production, but the trends come together synergistically in ways that are surprising.

The shale revolution could, in fact, prove to be a critical and helpful partner for EVs in two ways: First, EVs have to be charged with electricity produced by some means, and many do so with power from natural gas-fired power plants. Second, it turns out that the wastewater from shale production in certain regions of the U.S. has relatively high concentrations of lithium, which could be recovered and used to make the lithium-ion batteries necessary for EVs.

Doug Cole, Chairman & Chief Executive Officer of LithiumOre, commented, “With new ‘Green’ extraction and processing technology in the Lithium industry, there is a new element called ‘petrolithium.’ Petrolithium has a concentration of lithium carbonate that is 95 percent or greater. The technology at the forefront of this industry-changing process is specific gravity separation technology, which produces petrolithium by efficiently treating lithium ladened brine water in an environmentally friendly and low-cost manner.”

We now have a new way to extract a rare ‘superfuel’ – and it could be the most important energy development since shale oil went commercial. Oh, and it only takes a day. This ‘superfuel’ is the foundation of everything that defines our high-tech future – from crazed demand for rechargeable batteries, energy storage systems and electric vehicles, to the millions of consumer electronics we boost demand for daily. The superfuel is lithium, and the craze is already on. But we won’t have enough – not because we can’t find it. Lithium is abundant. It’s because demand is skyrocketing and we haven’t been able to extract it for a reasonable cost – until now.

Goldman Sachs Group projects that demand for lithium will triple by 2025 to 570,000 tons. Credit Suisse forecasts that demand for lithium “will actually outstrip supply as we approach the later part of the decade, with demand potentially as high as 125 percent of total capacity.” As our tech-driven energy future unfolds in front of us and becomes a critical reality, there is nothing more important than diversifying our lithium supply – but the difficulties of extraction make this challenging. Now we have an answer: It’s “petrolithium” – a new mining pioneered by a little-known company that has just made one of the biggest leaps in lithium deposits and innovative extraction technology.

LithiumOre holds 260 accepted lithium mineral claims, totaling 5,200 acres, located in the Western Nevada Basin, situated in Railroad Valley in Nye County, Nevada. Railroad Valley is approximately 112 miles northeast of Clayton Valley and can be accessed by paved highway directly from U.S. Route 6. Railroad Valley is one of Nevada’s largest trapped basins and is noted to hold all the necessary commercial and engineering prerequisites for a massive lithium brine deposit. The Company’s claims have been evaluated by experts and the BLM and are targeted for planned on-site exploration expected to begin by mid-2018.

LithiumOre, Corp.

LithiumOre (http://lithiumore.net), a wholly-owned subsidiary of Oroplata Resources, Inc. (OTCQB: ORRP), is a lithium resource exploration and development company, whose primary focus is the establishment of a low cost production base to supply the rapidly growing lithium-ion battery industry for both mobile devises and laptops, as well as the burgeoning EV (electronic vehicle) industry. LithiumOre is focused on becoming a substantial, profitable lithium producer via the timely development of valuable production-grade lithium brine deposits in Nevada.

For more information, please visit: http://lithiumore.net

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are “forward-looking statements.” Although the Company’s management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2017. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Contact Information

Hayden IR
Stephen Hart
(917) 658-7878
hart@haydenir.com

SOURCE: Oroplata Resources, Inc.

ReleaseID: 501363

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Oragenics and Sigma Labs were both big winners in the biotech arena on Wednesday. Shares of Oragenics climbed higher after announcing positive results from its interim safety analysis on patients from its Phase 2 clinical trial of AG013. AG013 is a promising product for the prevention of oral mucositis in cancer patients. Shares of Sigma Labs exploded after the company announced that it had demonstrated proof of concept for closed loop quality control during metal additive manufacturing.

RDI Initiates Coverage on:

Oragenics, Inc.
https://rdinvesting.com/news/?ticker=OGEN

Sigma Labs, Inc.
https://rdinvesting.com/news/?ticker=SGLB

Oragenics, Inc. was one of the biggest winners on the NYSE yesterday with a close in the green of 66.67%. The stock traded around 17.1 million shares compared to an average of about 712,000 shares. Shares moved higher after the company announced positive results from its interim safety analysis as requested by FDA on patients from its Phase 2 clinical trial of AG013 for the treatment of Oral Mucositis (OM). The data was reviewed by independent Data Safety Monitoring Board (DSMB), which said that the clinical trial can proceed with no changes to the study. CEO Alan Joslyn commented, “We are pleased with the conclusions reached by the DSMB. Of particular interest was the low number of study discontinuations due to the development of severe OM which resulted in patients seeking alternative treatments for their condition. We are also pleased to note that we believe the overall incidence of severe OM is less than would be anticipated in the general population. While recognizing the preliminary nature of this phase of the study, such a finding might well suggest mitigation of severe OM by AG013.” Joslyn added, “Given the clearance by the DSMB, we will proceed with patient enrollment for our AGO13 clinical trial, which we hope to accelerate by the addition of clinical sites in the U.S. and Europe. We expect to report top-line results of the completed phase 2 trial in late 2019.”

Access RDI’s Oragenics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OGEN

Sigma Labs, Inc. shares were on a rampage in Wednesday trading, closing the day up almost 50%. The stock saw colossal trading volume compared to usual with a little over 27 million shares versus an average of about 465,000 shares. The provider of quality assurance software under the PrintRite3D® brand, announced that it has developed and demonstrated closed-loop feedback control of the metal laser powder bed fusion 3D printing process. According to the company’s press release, “Using Sigma’s PrintRite3D® technology, the system operates by monitoring the process output and extracting process metrics. The process metrics are then compared to baseline metrics. The system then determines what process input parameter values need to be changed and implements those remedial changes in real time by signaling a change in the laser power in order to maintain the process under control.” CTO Mark Cola remarked, “Automatic feedback process control was the next step in completing Sigma Labs’ suite of sensing, monitoring, and control capabilities of metal additive manufacturing (AM) processes.” He added, “By achieving this advanced understanding of quality variation and machine learning for metal AM machines that the Factories of the Future require, Sigma Labs has demonstrated that it is possible to bring the future to the present.”

Access RDI’s Sigma Labs, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SGLB

Our Actionable Research on Oragenics, Inc. (NYSE: OGEN) and Sigma Labs, Inc. (NASDAQ: SGLB) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501345

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / U.S. equities rebounded on Wednesday, lifted by strong performance from the energy sector and worries over Italy’s political crisis eased. The Dow Jones Industrial Average increased 1.26 percent to close at 24,667.78, while the S&P 500 Index climbed 1.27 percent to close at 2,724.01. The Nasdaq Composite Index was up 0.89 percent to close at 7,462.45.

“The fact that the market is shrugging off Italy’s political drama suggests that maybe it was a crowded trade that was being unwound and not something more serious,” said Michael Antonelli, equity sales trader at Robert W. Baird & Co.

“Anything coming from the left field can shatter markets nowadays, so we have to brace for a long summer grind,” Antonelli added.

RDI Initiates Coverage on:

CRISPR Therapeutics AG
https://rdinvesting.com/news/?ticker=CRSP

Editas Medicine, Inc.
https://rdinvesting.com/news/?ticker=EDIT

CRISPR Therapeutics’ stock jumped 6.79% Wednesday, to close the day at $73.59. The stock recorded a trading volume of 1,736,916 shares, which was above its three months average volume of 1,372,240 shares. In the last year, CRISPR Therapeutics’ shares have traded in a range of 13.54 – 73.90. The share price has gained 443.50% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $55.67 is above its 200-day moving average of $39.79. Shares of CRISPR Therapeutics have gained roughly 57.04 percent in the past month and are up 213.42 percent year-to-date.

Access RDI’s CRISPR Therapeutics AG Research Report at:
https://rdinvesting.com/news/?ticker=CRSP

On Wednesday, shares of Editas Medicine recorded a trading volume of 979,114 shares, which was below the three months average volume of 1,234,907 shares. The stock ended the day 6.4% higher at $37.93. The share price has fallen 15.75% from its 52 week high with a 52 week trading range of 13.20 – 45.02. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $34.49 is above its 200-day moving average of $32.95. Shares of Editas Medicine have gained roughly 20.8 percent in the past month and are up 23.43 percent year-to-date.

Access RDI’s Editas Medicine, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=EDIT

Our Actionable Research on CRISPR Therapeutics AG (NASDAQ:CRSP) and Editas Medicine, Inc. (NASDAQ:EDIT) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501346

NEW YORK, NY / ACCESSWIRE / May 31, 2018 / U.S. equities rebounded on Wednesday, lifted by strong performance from the energy sector and worries over Italy’s political crisis eased. The Dow Jones Industrial Average increased 1.26 percent to close at 24,667.78, while the S&P 500 Index climbed 1.27 percent to close at 2,724.01. The Nasdaq Composite Index was up 0.89 percent to close at 7,462.45.

“The fact that the market is shrugging off Italy’s political drama suggests that maybe it was a crowded trade that was being unwound and not something more serious,” said Michael Antonelli, equity sales trader at Robert W. Baird & Co.

“Anything coming from the left field can shatter markets nowadays, so we have to brace for a long summer grind,” Antonelli added.

RDI Initiates Coverage on:

iQIYI, Inc.
https://rdinvesting.com/news/?ticker=IQ

Snap Inc.
https://rdinvesting.com/news/?ticker=SNAP

iQIYI’s stock jumped 11.40% Wednesday, to close the day at $25.71. The stock recorded a trading volume of 16,811,929 shares, which was above its three months average volume of 9,503,141 shares. In the last year, iQIYI’s shares have traded in a range of 15.30 – 25.99. The share price has gained 68.04% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $19.58 is greater than its 200-day moving average of $18.93. Shares of iQIYI have gained roughly 42.60 percent in the past month and are up 65.34 percent year-to-date.

Access RDI’s iQIYI, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IQ

On Wednesday, shares of Snap recorded a trading volume of 28,700,074 shares, which was above the three months average volume of 24,370,193 shares. The stock ended the day 3.98% higher at 10.97. The stock is currently trading 48.86% below its 52 week high with a 52 week trading range of 10.50 – 21.45. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $12.51 is below its 200-day moving average of $14.70. Shares of Snap have fallen roughly 23.45 percent in the past month and are down 24.91 percent year-to-date.

Access RDI’s Snap Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SNAP

Our Actionable Research on iQIYI, Inc. (NASDAQ:IQ) and Snap Inc. (NYSE:SNAP) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 501347